Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc C Peden

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Plos One|February 25, 2011
Ab-externo AAV-mediated gene delivery to the suprachoroidal space using a 250 micron flexible microcatheterMarc C Peden, Jeff Min, Craig Meyers, et al.
Human Molecular Genetics|October 5, 2018
Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degenerationJason Charng, Artur V Cideciyan, Samuel G Jacobson, et al.
Human Molecular Genetics|November 1, 2016
Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degenerationJason Charng, Artur V Cideciyan, Samuel G Jacobson, et al.
Human Gene Therapy. Clinical Development|May 23, 2013
Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosaThomas J Conlon, Wen-Tao Deng, Kirsten Erger, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 14, 2011
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 yearsSamuel G Jacobson, Artur V Cideciyan, Ramakrishna Ratnakaram, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Plos One|February 25, 2011
Ab-externo AAV-mediated gene delivery to the suprachoroidal space using a 250 micron flexible microcatheterMarc C Peden, Jeff Min, Craig Meyers, et al.
Human Molecular Genetics|October 5, 2018
Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degenerationJason Charng, Artur V Cideciyan, Samuel G Jacobson, et al.
Human Molecular Genetics|November 1, 2016
Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degenerationJason Charng, Artur V Cideciyan, Samuel G Jacobson, et al.
Human Gene Therapy. Clinical Development|May 23, 2013
Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosaThomas J Conlon, Wen-Tao Deng, Kirsten Erger, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 14, 2011
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 yearsSamuel G Jacobson, Artur V Cideciyan, Ramakrishna Ratnakaram, et al.
Pageof 2